Skip to main content
Article
Licensed
Unlicensed Requires Authentication

Prevalence of pseudonatremia in a clinical laboratory – role of the water content

  • , , and EMAIL logo
Published/Copyright: September 27, 2016

Abstract

Background:

Sodium concentration is a frequently used marker to discriminate between differential diagnoses or for clinical follow-up. Pseudonatremia, as a result of indirect ion-selective electrode (ISE) measurements in automated chemistry analyzers, can lead to incorrect diagnosis and treatment. We investigated whether the estimated water content, based on total protein and lipid concentrations, can be used to reduce diagnoses of pseudonatremia.

Methods:

Indirect and direct ISE measurements of sodium were compared in blood samples from intensive care unit (ICU) (n = 98) and random non-ICU patients (n = 100). Differences between direct measurements using whole blood and lithium-heparin plasma were also determined. Water content, estimated by a linear combination of total protein and lipid concentrations, was used to correct indirectly measured sodium concentrations. The prevalence of pseudonatremia was evaluated in the ICU patient group.

Results:

An absolute difference of 3 mmol/L was observed between direct measurements using lithium-heparin plasma and whole blood, with higher concentrations in plasma. Additionally, we observed that differences between indirect and direct measurements displayed a linear relationship with the estimated water content. The prevalence of pseudohypernatremia after indirect measurements (32%) was reduced when measurements were corrected for water content (19%).

Conclusions:

In critically ill patients, sodium concentrations should be preferably measured by direct measurements. Whole blood is the preferred material for these measurements. For routine sodium analyses in other patients, correction using the estimated water content appears promising in reducing the prevalence of pseudohypernatremia by indirect measurements.

Acknowledgments

The authors would to thank Stan van Dijk, Inge Bakker, and John Benco (Siemens diagnostics) as well as Maarten Nijsten and Annemieke Oude Lansink-Hartgring (University Medical Centre Groningen) for helpful suggestions and discussions.

  1. Author contributions:All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership:None declared.

  4. Honorarium: None declared.

  5. Competing interests:The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Bhattacharjee D, Page S. Hypernatraemia in adults: a clinical review. Acute Med 2010;9:60–5.10.52964/AMJA.0383Search in Google Scholar

2. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–29.10.1097/00003246-198510000-00009Search in Google Scholar

3. Hoorn E, Tuut M, Hoorntje S, van Saase J, Zietse R, Geers A. Dutch guideline for the management of electrolyte disorders-2012 revision. Neth J Med 2013;71:153–65.Search in Google Scholar

4. Darmon M, Timsit JF, Francais A, Nguile-Makao M, Adrie C, Cohen Y, et al. Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant 2010;25:2510–5.10.1093/ndt/gfq067Search in Google Scholar PubMed

5. Joosen AM, Boonen K, Hulsman N, Schuitemaker FJ, Thelen MH. Hypernatraemia in disguise. Clin Chem Lab Med 2014;52:e231–4.10.1515/cclm-2014-0474Search in Google Scholar PubMed

6. Dimeski G, Morgan TJ, Presneill JJ, Venkatesh B. Disagreement between ion selective electrode direct and indirect sodium measurements: estimation of the problem in a tertiary referral hospital. J Crit Care 2012;27:326.e9–16.10.1016/j.jcrc.2011.11.003Search in Google Scholar PubMed

7. Jelinek AG, Bachmann LM. Unexpected test results in a patient with multiple myeloma. Clin Chem 2014;60:1375–8.10.1373/clinchem.2013.213884Search in Google Scholar PubMed

8. Turchin A, Seifter JL, Seely EW. Clinical problem-solving. Mind the gap. N Engl J Med 2003;349:1465–9.10.1056/NEJMcps031078Search in Google Scholar PubMed

9. Lai MY, Lin CC, Chung SL, Wu CH, Yang WC, Tseng YT. Milky plasma, diabetes, and severe hyponatremia. Kidney Int 2009;75:996.10.1038/ki.2008.335Search in Google Scholar PubMed

10. van den Ancker W, Haagen IA, van der Voort PH. Direct sodium measurement prevents underestimation of hyponatremia in critically ill patients. Intensive Care Med 2015;41:553–4.10.1007/s00134-014-3623-ySearch in Google Scholar PubMed

11. Burnett RW, Covington AK, Fogh-Andersen N, Kulpmann WR, Lewenstam A, Maas AH, et al. Recommendations for measurement of and conventions for reporting sodium and potassium by ion-selective electrodes in undiluted serum, plasma or whole blood. IFCC Scientific Division Working Group on Selective Electrodes. Clin Chem Lab Med 2000;38:1065–71.10.1515/CCLM.2000.159Search in Google Scholar PubMed

12. Levy GB. Determination of sodium with ion-selective electrodes. Clin Chem 1981;27:1435–8.10.1093/clinchem/27.8.1435Search in Google Scholar

13. Waugh WH. Utility of expressing serum sodium per unit of water in assessing hyponatremia. Metabolism 1969;18:706–12.10.1016/0026-0495(69)90085-7Search in Google Scholar

14. Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO, Needham LL. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 1989;18:495–500.10.1007/BF01055015Search in Google Scholar

15. Dimeski G, Barnett RJ. Effects of total plasma protein concentration on plasma sodium, potassium and chloride measurements by an indirect ion selective electrode measuring system. Crit Care Resusc 2005;7:12–5.Search in Google Scholar

16. Dimeski G, Mollee P, Carter A. Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring system. Clin Chem 2006;52:155–6.10.1373/clinchem.2005.054981Search in Google Scholar

17. Chow E, Fox N, Gama R. Effect of low serum total protein on sodium and potassium measurement by ion-selective electrodes in critically ill patients. Br J Biomed Sci 2008;65:128–31.10.1080/09674845.2008.11732815Search in Google Scholar

18. Lang T, Prinsloo P, Broughton AF, Lawson N, Marenah CB. Effect of low protein concentration on serum sodium measurement: pseudohypernatraemia and pseudonormonatraemia. Ann Clin Biochem 2002;39:66–7.10.1258/0004563021901586Search in Google Scholar

19. Story DA, Morimatsu H, Egi M, Bellomo R. The effect of albumin concentration on plasma sodium and chloride measurements in critically ill patients. Anesth Analg 2007;104:893–7.10.1213/01.ane.0000258015.87381.61Search in Google Scholar

20. Siggaard-Andersen O, Fogh-Andersen N. The erythrocyte effect on the liquid junction potential: an osmotic dilution phenomenon. IFCC Workshop 1989;10:235–41.Search in Google Scholar

21. Maas AH. pH determination of body fluids with a micro glass electrode and a saturated KC1 bridge in the cell. Clin Chim Acta 1970;28:373–90.10.1016/0009-8981(70)90062-8Search in Google Scholar

22. Goldwasser P, Ayoub I, Barth RH. Pseudohypernatremia and pseudohyponatremia: a linear correction. Nephrol Dial Transplant 2015;30:252–7.10.1093/ndt/gfu298Search in Google Scholar PubMed

23. Jones BJ, Twomey PJ. Relationship of the absolute difference between direct and indirect ion selective electrode measurement of serum sodium and the total protein concentration. J Clin Pathol 2008;61:645–7.10.1136/jcp.2007.050872Search in Google Scholar PubMed

24. Marik PE. Dyslipidemia in the critically ill. Crit Care Clin 2006;22:151–9, viii.10.1016/j.ccc.2005.08.008Search in Google Scholar PubMed

25. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med 2001;29:1563–8.10.1097/00003246-200108000-00011Search in Google Scholar PubMed


Supplemental Material:

The online version of this article (DOI: 10.1515/cclm-2016-0401) offers supplementary material, available to authorized users.


Received: 2016-5-6
Accepted: 2016-8-19
Published Online: 2016-9-27
Published in Print: 2017-3-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The central role of external quality assurance in harmonisation and standardisation for laboratory medicine
  4. Review
  5. Fecal calprotectin in inflammatory bowel diseases: update and perspectives
  6. Mini Review
  7. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation
  8. Opinion Papers
  9. Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE)
  10. Metabolite profiling can change health-care delivery to obese patients with fatty liver disease: the search for biomarkers
  11. Genetics and Molecular Diagnostics
  12. Rapid screening for targeted genetic variants via high-resolution melting curve analysis
  13. Evaluation of the new cobas® HCV genotyping test based on real-time PCRs of three different HCV genome regions
  14. General Clinical Chemistry and Laboratory Medicine
  15. Harmonisation of serum dihydrotestosterone analysis: establishment of an external quality assurance program
  16. Spanish Preanalytical Quality Monitoring Program (SEQC), an overview of 12 years’ experience
  17. Peer groups splitting in Croatian EQA scheme: a trade-off between homogeneity and sample size number
  18. Prevalence of pseudonatremia in a clinical laboratory – role of the water content
  19. Retrospective validation of a β-trace protein interpretation algorithm for the diagnosis of cerebrospinal fluid leakage
  20. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective
  21. Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study
  22. Clinical autoantibody detection by microarray
  23. Cardiovascular Diseases
  24. Kinetics of troponin I in patients with myocardial injury after noncardiac surgery
  25. Infectious Diseases
  26. P35 and P22 Toxoplasma gondii antigens abbreviate regions to diagnose acquired toxoplasmosis during pregnancy: toward single-sample assays
  27. Letters to the Editor
  28. Deciphering a macro-troponin I complex; a case report
  29. Interference of laboratory disinfection with trichloro-isocyanuric acid on cardiac troponin I measurement using the Vitros immunoassay system
  30. Massive interference in free T4 and free T3 assays misleading clinical judgment
  31. In defense of aldosterone measurement by immunoassay: a broader perspective
  32. The prevalence of hemolysis – a survey using hemolysis index
  33. Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma
  34. Evaluation of the accuracy of the Greiner Bio-One FC Mix Glucose tube
  35. Congress Abstracts
  36. 4th EFLM-BD European Conference on Preanalytical Phase Amsterdam (NL), 24–25 March 2017
Downloaded on 2.5.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-0401/html?lang=en
Scroll to top button